Jos van der Meer

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 22:32, April 26, 2018 by Kmdenmark (talk | contribs) (added study and ref)

Jos W.M. van der Meer, MD, PhD, is emeritus professor and former Head of the Department of General Internal Medicine, of the Radboud University Nijmegen Medical Centre in Nijmegen, Netherlands. His professional achievements include serving as Vice president of the Royal Netherlands Academy of Arts and Sciences from 2006 - 2011; Chairman of Natural Science Division of the Royal Netherlands Academy of Arts and Sciences; and being a member of the Academia Europaea (Academy of Europe).[1]

His special interests include: Natural immunity, Cytokines, Autoinflammatory disorders, Hyper-IgD syndrome, Chronic fatigue syndrome, and Antibiotic stewardship.[2]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube

Learn more[edit | edit source]

  • Wikipedia

See also[edit | edit source]

References[edit | edit source]

  1. http://www.ae-info.org/ae/Member/van_der_Meer_Jos
  2. http://www.ae-info.org/ae/Member/van_der_Meer_Jos
  3. van der Schaaf ME, Roelofs K, de Lange FP, Geurts DEM, van der Meer JWM, Knoop H, Toni I. (2018). Fatigue Is Associated With Altered Monitoring and Preparation of Physical Effort in Patients With Chronic Fatigue Syndrome. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Apr;3(4):392-404. doi: 10.1016/j.bpsc.2018.01.015.
  4. Roerink, M. E., Knoop, H., Bronkhorst, E. M., Mouthaan, H. A., Hawinkels, L. J. A. C., Joosten, L. A. B., & van der Meer, J. W. M. (2017). Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment. Journal of Translational Medicine, 15, 267. http://doi.org/10.1186/s12967-017-1371-9
  5. Janse A, Nikolaus S, Wiborg JF, Heins M, van der Meer JWM, Bleijenberg G, Tummers M, Twisk J, Knoop H. (2017). Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome. J Psychosom Res. 2017 Jun;97:45-51. doi: 10.1016/j.jpsychores.2017.03.016.
  6. Roerink ME, Bredie SJH, Heijnen M, Dinarello CA, Knoop H, Van der Meer JWM. (2017). Cytokine Inhibition in Patients With Chronic Fatigue Syndrome: A Randomized Trial. Annals of Intern Med. 2017 Apr 18;166(8):557-564. doi: 10.7326/M16-2391
  7. van der Schaaf ME, De Lange FP, Schmits IC, Geurts DEM, Roelofs K, van der Meer JWM, Toni I, Knoop H. (2017). Prefrontal Structure Varies as a Function of Pain Symptoms in Chronic Fatigue Syndrome. Biological Psychiatry. 2017 Feb 15;81(4):358-365. doi: 10.1016/j.biopsych.2016.07.016.
  8. Roerink ME, Lenders JW, Schmits IC, Pistorius AM, Smit JW, Knoop H, van der Meer JW. (2107). Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome. J Intern Med. 2017 Feb;281(2):179-188. doi: 10.1111/joim.12564
  9. Keijmel SP, Saxe J, van der Meer JW, Nikolaus S, Netea MG, Bleijenberg G, Bleeker-Rovers CP, Knoop H. (2015) A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour. Journal of Psychosomatic Research 79(4):295-302. doi: 10.1016 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26272528
  10. Prins, Judith B.; Bleijenberg, Gijs; Rouweler, Eufride Klein; van Weel, Chris; van der Meer, Jos W. M. (2000), "Doctor-Patient Relationship in Primary Care of Chronic Fatigue Syndrome", Journal of Chronic Fatigue Syndrome, 7 (4): 3-15, doi:10.1300/J092v07n04_02